Engineered Human Myocardium (EHM) Patch
Advanced Heart Failure
Phase 1Active
Key Facts
About Repairon
Repairon is a private, clinical-stage biotech based in Munich, Germany, developing iPSC-derived engineered heart muscle (EHM) patches for the treatment of advanced heart failure. The company has advanced its lead program into a first-in-human clinical trial (BioVAT-HF) and has established GMP manufacturing for its investigational products. With a strong IP position in tissue engineering and a leadership team combining deep scientific expertise with successful biotech commercialization experience, Repairon is positioned at a key value inflection point as it generates initial clinical data for its novel regenerative therapy.
View full company profileTherapeutic Areas
Other Advanced Heart Failure Drugs
| Drug | Company | Phase |
|---|---|---|
| ICOMS Flowmaker® | FineHeart | First-In-Human (FIH) |